Sofinnova Partners announced the successful close of Sofinnova Digital Medicine I at $200 million, significantly exceeding its target.
Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the successful close of Sofinnova Digital Medicine I at $200 million (€190M), significantly exceeding its target. The fund, spearheaded by Partners Edward Kliphuis…